VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $9,272,000 | -19.7% | 51,979 | 0.0% | 1.64% | -12.0% |
| Q2 2015 | $11,547,000 | +11.8% | 51,979 | 0.0% | 1.86% | +18.3% |
| Q1 2015 | $10,324,000 | +38.8% | 51,979 | 0.0% | 1.57% | +37.3% |
| Q4 2014 | $7,439,000 | +9.1% | 51,979 | 0.0% | 1.14% | +1.4% |
| Q3 2014 | $6,820,000 | +4.0% | 51,979 | 0.0% | 1.13% | +4.6% |
| Q2 2014 | $6,556,000 | -4.3% | 51,979 | 0.0% | 1.08% | -7.9% |
| Q1 2014 | $6,852,000 | +12.3% | 51,979 | 0.0% | 1.17% | +11.6% |
| Q4 2013 | $6,102,000 | +12.5% | 51,979 | 0.0% | 1.05% | +4.7% |
| Q3 2013 | $5,423,000 | +21.2% | 51,979 | 0.0% | 1.00% | +17.7% |
| Q2 2013 | $4,474,000 | +14.7% | 51,979 | 0.0% | 0.85% | +14.8% |
| Q1 2013 | $3,899,000 | – | 51,979 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |